Industry Sees Room For Better Diagnostics Payments In Medicare Package
This article was originally published in The Gray Sheet
Executive Summary
Public sign-on by a prominent member of the Senate Finance Committee could help an industry-backed diagnostic test reimbursement bill get tucked into a Medicare package on path for possible passage by year-end
You may also be interested in...
Lab Tests Face Revaluation, Cuts Under New CMS Proposals
CMS proposes a comprehensive review process to ensure test payments account for changes in technology. The effort would likely lead to pay reductions in many instances to address new efficiencies in the lab. In addition, double-digit cuts in lab payments are contained in the agency’s 2014 physician fee schedule proposal.
Lab Tests Face Revaluation, Cuts Under New CMS Proposals
CMS is proposing a comprehensive review process to ensure test payments account for changes in technology. The effort would likely lead to pay reductions in many instances to address new efficiencies in the lab. In addition, double-digit cuts in lab payments are proposed in the agency’s 2014 physician fee schedule draft.
BIO Plans Lobbying Push To Improve Payments For Diagnostics
The Biotechnology Industry Organization is adding its lobbying muscle to diagnostic industry efforts to improve payment policies for molecular tests, hoping for a warm reception from lawmakers who are already focused on personalized medicine issues.